“The cyber-attack led to a disruption of our worldwide operations, including research” – Merck, following the June 27, 2017 malware attack.

Data security is critical to many aspects of the biotechnology, medical technology and pharmaceutical sector – from protecting IP and trade secrets, stewardship of clinical and patient data and ensuring the integrity of company information. It should cause us to reconsider how we describe risk, think about what it means to be secure, and the tools we use to stay safe.

In this BioBriefing, Warren Dunn, Fraud Investigations and Dispute Services Partner at EY and Alec Christie, Digital Law Partner at EY, will discuss the issues of cyber security, data stewardship and what the life sciences sector needs to be aware of with the new mandatory data breach laws coming into effect in Australia.  They will also provide a case study to examine how an organisation dealt with data breaches.

Date:                Tuesday 19^th September, 2017
Time:               3:45 registration for 4:00pm – 5:00pm followed by a networking session
Venue:             EY, Level 23, Exhibition Street, Melbourne

Cost:
Members: $65
Non Members: $130

Check if your organisation is a member here

About the Speakers:

Alec Christie, Digital Law Partner, EY

 Alec is the head of Digital Law in Australia at EY. He has been recognised by Best Lawyers Australia as one of Australia’s top Outsourcing lawyers and by Who’s Who Legal as one of Australia’s best Information Technology lawyers, specifically known for privacy. He has particular expertise in providing Digital Law solutions in the financial services, health/life sciences, on-line media and entertainment sectors and Government.

 

Warren Dunn, FIDS Partner, EY

Warren is a Partner in the Fraud Investigations and Disputes Services division at EY and leads our forensic technology competency across Australia.  He has over 18 years’ experience in providing comprehensive cyber/IT forensics, eDiscovery and forensic data analytic consulting services.